Smpc Combisal 2020 2020-04-20T12:32:47+00:00

This area of the website is password protected.

For regulatory reasons we are not able to provide further details on our products on this website without a login to the password protected area.

HEALTHCARE PROFESSIONALS

Summary of Product
Characteristics

Combisal Summary of Product Characteristics

These links will take you to the electronic Medicines Compendium (eMC) website.
Combisal? 25μg/50μg metered dose inhaler
Combisal? 25μg/125μg metered dose inhaler
Combisal? 25μg/250μg metered dose inhaler

For further information please call: 01730 231148, email: info@www.soyporteno.com or visit www.www.soyporteno.com

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to Aspire Pharma Ltd on 01730 231148
For more information about Combisal, please see the abbreviated prescribing information.
Revision reference 4.0 – Combisal 17/04/2020
桃红色界